Home > Healthcare > Drug Device Combination > Radiopharmaceuticals Market

Radiopharmaceuticals Market Share

  • Report ID: GMI10918
  • Published Date: Aug 2024
  • Report Format: PDF

Radiopharmaceuticals Market Share

The market is competitive, featuring both major pharmaceutical companies and specialized firms. Key players differentiate themselves through technological advancements, extensive R&D, and strategic partnerships. Established companies leverage their resources and global reach, while emerging players focus on niche innovations and novel therapies. Regulatory compliance and quality are critical, with firms needing to meet stringent standards. Additionally, competition is influenced by pricing strategies and customer service, as companies aim to offer value and exceptional support. Overall, the market is dynamic, driven by continuous innovation and a focus on maintaining high standards in product development and customer care.
 

Radiopharmaceuticals Market Companies

Prominent players operating in the radiopharmaceuticals industry industry include:

  • Bayer AG
  • Bracco
  • Cardinal Health Inc.
  • Coquí Radiopharmaceuticals Corp
  • Curium Pharma
  • Eli Lilly and Company
  • General Electric Company
  • IRE ELiT
  • Iso-Tex Diagnostics, Inc
  • Jubilant Pharmova Limited
  • Lantheus
  • Novartis AG
  • SHINE Technologies, LLC
  • Telix Pharmaceuticals Limited
     
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Radiopharmaceuticals industry size was worth USD 6.7 billion in 2023 and will grow at a 9.8% CAGR between 2024 and 2032, driven by the rising prevalence of cancer and cardiovascular diseases

Radiopharmaceuticals industry from the diagnostic segment captured 72.6% share in 2023, primarily due to increasing use in imaging techniques like PET and SPECT scans.

North America radiopharmaceuticals industry will record 9.2% CAGR through 2032, propelled by its advanced healthcare infrastructure, significant investments in nuclear medicine, and strong presence of key market players.

Some of the prominent radiopharmaceuticals industry players are Bayer AG, Bracco, Cardinal Health Inc., Coquí Radiopharmaceuticals Corp, Curium Pharma, Eli Lilly and Company, General Electric Company, IRE EliT, Iso-Tex Diagnostics, Inc, Jubilant Pharmova Limited, Lantheus, Novartis AG, SHINE Technologies, LLC, and Telix Pharmaceuticals Limited, among others.

Radiopharmaceuticals Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 14
  • Tables & Figures: 215
  • Countries covered: 23
  • Pages: 110
 Download Free Sample